|会社名||Humana Inc. （HUM ヒュ―マナ）|
|概要||事業概要 ヒューマナ(Humana Inc.)は健康と福祉を提供する会社である。同社はリテール事業、グループと専門、ヘルスケアサービス、個人商業の4つの事業区分により構成される。リテール事業は歯科、ビジョン、その他の保健・消費者保護商品を含むメディケア福祉給付を含む。ヘルスケアサービス事業は、保健計画メンバーと第三者向けに、薬局ソリューション、プロバイダーサービス、家庭ベースのサービスと臨床プログラム、並びに住民の健康の管理などのサービスを提供する。個人商業事業は「HumanaOne」というブランドで販売される個人向けの商用製品を提供する。 ヒュ―マナは医療保険と補完保険を提供する持ち株会社。事業は個人、事業主、健康・福利厚生で構成。個人・企業に各種医療保険、メディケア、歯科や眼科保険などの特殊保険商品や生命保険を提供する。同社の医療保険加入者にプライマリ―ケア、薬剤給付、健康管理、在宅ケアサ―ビスを提供する。その他事業として、トライケアやメディケイドも扱う。 Humana Inc. is committed to helping its millions of medical and specialty members achieve their best health. Its successful history in care delivery and health plan administration is helping it create a new kind of integrated care with the power to improve health and well-being and lower costs. Its efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.|
|代表者氏名||Kurt J. Hilzinger|
|代表者役職名||Independent Chairman of the Board|
|決算概要||決算概要 BRIEF: For the fiscal year ended 31 December 2018 Humana Inc revenues increased 6% to $56.91B. Net income before extraordinary items decreased 33% to $1.72B. Revenues reflect Retail segment increase of 8% to $48.12B Health_Well Bing Services segment increase of 80% to $607M Medical Expense Ratio -%-Retail decrease of 1% to 85.1% General_Administration Ratio Total -% increase of 8% to 13.3%.|
Humana Inc. – Consensus Indicates Potential 13.2% Upside 2022/06/09 11:45:19 DirectorsTalk
Humana Inc. found using ticker (HUM) have now 22 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 578 and 450 with the average target price sitting at 509.14. Given that the stocks previous close was at 449.78 this would indicate that there is a potential upside of 13.2%. The day 50 moving average is 444 while the 200 day moving average is 430.35. The market cap for the company is $56,988m. Company Website: https://www.humana.com [stock_market_widget type="chart" template="basic" color="green" assets="HUM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $64,509m based on the market concensus. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Wednesday, June 8, 2022: Cramer breaks down outlook on Halliburton, Humana, Nvidia and more 2022/06/08 14:46:39 CNBC
Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market''s biggest headlines, analyst calls and holdings in the Charitable Trust—and see up close how they decide when, and if, to take action on stocks.
U.S. FTC launches inquiry into drug middlemen 2022/06/07 17:40:50 Financial Post
The Federal Trade Commission said on Tuesday it will launch an inquiry into the prescription drug middleman industry, sending compulsory orders to six pharmacy benefit managers for records on their business practices. As part of the inquiry, the antitrust body will send orders to CVS Health Corp’s Caremark, Humana Inc, Cigna Corp’s Express Scripts and […]
Humana Inc. to Present at the Jefferies Healthcare Conference 2022/05/31 20:30:00 Business Wire
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 11:30 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a syste
Why Humana Inc. (NYSE: HUM) Stock Shouldn’t Be Ignored In 2022 2022/05/30 15:00:00 Marketing Sentinel
In the last trading session, 0.52 million shares of the Humana Inc. (NYSE:HUM) were traded, and its beta was 0.86. Most recently the company’s share price was $461.21, and it changed around $8.99 or 1.99% from the last close, which brings the market valuation of the company to $57.20B. HUM currently trades at a discount … Why Humana Inc. (NYSE: HUM) Stock Shouldn’t Be Ignored In 2022 Read More »
Hummingbird Resources PLC -27.3% potential downside indicated by Berenberg Bank 2022/03/03 10:01:54 DirectorsTalk
Hummingbird Resources PLC with ticker (LON:HUM) now has a potential downside of -27.3% according to Berenberg Bank. [stock_market_widget type="chart" template="basic" color="green" assets="HUM.L" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] Berenberg Bank set a target price of 12 GBX for the company, which when compared to the Hummingbird Resources PLC share price of 15 GBX at opening today (03/03/2022) indicates a potential downside of -27.3%. Trading has ranged between 11 (52 week low) and 24 (52 week high) with an average of 1,291,831 shares exchanging hands daily. The market capitalisation at the time of writing is £60,143,286. Humana Inc. is a health and well-being company. The Company''s segments include Retail, Group and Specialty and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or via group Medicare accounts. The Group and Specialty segment consists of employer group commercial insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only (ASO) products.
Humana Inc. to Present at the Barclays Global Healthcare Conference 2022/02/28 21:30:00 Kwhen Finance
Insurer Humana, Starboard agree to add independent directors 2022/02/22 14:42:19 ABC News
Humana is adding two more independent directors to its board under an agreement with activist hedge fund Starboard Value
Humana appoints two new directors to board 2022/02/22 13:27:06 Investing.com
CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low 2022/01/07 20:52:27 InvestorPlace
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.
Humana selloff could be company specific, but too early to know, UBS says 2022/01/07 14:10:30 Seeking Alpha
UnitedHealth''s stock selloff chopping about 120 points off the Dow''s price 2022/01/06 18:47:49 MarketWatch
Shares of UnitedHealth Group Inc. dropped 3.7% in afternoon trading Thursday, enough to pace the Dow Jones Industrial Average''s components in declines. The $18.22 price decline in the health insurance company''s stock was shaving about 120 points off the price of the Dow, which was dropping 144 points, or 0.4%. In comparison, the S&P 500 was up 0.1%. The selloff in UnitedHealth''s stock comes after peer Humana Inc. slashed its estimate of 2022 Medicare Advantage membership growth, amid higher-than-expected terminations during the annual election period. Humana''s stock plunged 19.7%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Humana stock tumbles to pace S&P 500 losers after slashing Medicare Advantage membership growth view 2022/01/06 18:16:56 MarketWatch
Shares of Humana Inc. tumbled 13.0% toward a three-month low in afternoon trading Thursday, to pace the S&P 500''s decliners, after the health insurance services company slashed its full-year membership estimate for its Medicare Advantage products. Humana''s stock was headed for the biggest one-day selloff since it slid 13.9% on March 16, 2020. Humana disclosed earlier Thursday that it now expects 2022 net membership growth for its individual Medicare Advantage products of 150,000 to 200,000 members, down from a previous estimate of 325,000 to 375,000 due primarily to "higher than anticipated terminations" during the annual election period, combined with expectations of higher than originally expected terminations for the rest of 2022. The company expects 2022 adjusted earnings per share of approximately $20.50, compared with the FactSet consensus of $20.53. Meanwhile, for the Humana Premier Rx Plan (PDP), the company now estimates a net membership decline of 125,000 members in 2022, compared with previous estimates of a loss of "a few hundred thousand members," citing better-than-expected sales of the Walmart Value plan and lower-than-anticipated terminations.
関連キーワード （管理健康医療 米国株 HUM ヒュ―マナ HUM ）